Global Transdermal Patch Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
According to APO Research, The global Transdermal Patch market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%.
Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total.
Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019.
This report presents an overview of global market for Transdermal Patch, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Transdermal Patch, also provides the sales of main regions and countries. Of the upcoming market potential for Transdermal Patch, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Transdermal Patch sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Transdermal Patch market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Transdermal Patch sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Grьnenthal and IBSA Group, etc.
Transdermal Patch segment by Company
1. To analyze and research the global Transdermal Patch status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Transdermal Patch market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Transdermal Patch significant trends, drivers, influence factors in global and regions.
6. To analyze Transdermal Patch competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transdermal Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Transdermal Patch market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Transdermal Patch industry.
Chapter 3: Detailed analysis of Transdermal Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Transdermal Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Transdermal Patch in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Chapter 10: Concluding Insights.
According to APO Research, The global Transdermal Patch market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%.
Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total.
Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019.
This report presents an overview of global market for Transdermal Patch, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Transdermal Patch, also provides the sales of main regions and countries. Of the upcoming market potential for Transdermal Patch, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Transdermal Patch sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Transdermal Patch market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Transdermal Patch sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Grьnenthal and IBSA Group, etc.
Transdermal Patch segment by Company
- Hisamitsu Pharmaceutical
- Johnson & Johnson
- Novartis
- UCB Pharma
- Mylan
- Teva Pharmaceutical
- Nitto Denko
- Grьnenthal
- IBSA Group
- GSK
- Luye Pharma Group
- Pfizer
- Chattem
- Dr Reddy’s Laboratories
- Bayer
- Mundipharma
- Endo International
- Beijing Tide Pharmaceutical
- Methyl Salicylate-based Patch
- Rivastigmine Transdermal Patch
- Fentanyl Transdermal Patch
- Lidocaine Patch
- Diclofenac Patch
- Nicotine Transdermal Patch
- Others
- Rx Channel
- OTC Channel
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global Transdermal Patch status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Transdermal Patch market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Transdermal Patch significant trends, drivers, influence factors in global and regions.
6. To analyze Transdermal Patch competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transdermal Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Transdermal Patch market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Transdermal Patch industry.
Chapter 3: Detailed analysis of Transdermal Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Transdermal Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Transdermal Patch in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Chapter 10: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Transdermal Patch Sales Value (2019-2030)
1.2.2 Global Transdermal Patch Sales Volume (2019-2030)
1.2.3 Global Transdermal Patch Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 TRANSDERMAL PATCH MARKET DYNAMICS
2.1 Transdermal Patch Industry Trends
2.2 Transdermal Patch Industry Drivers
2.3 Transdermal Patch Industry Opportunities and Challenges
2.4 Transdermal Patch Industry Restraints
3 TRANSDERMAL PATCH MARKET BY COMPANY
3.1 Global Transdermal Patch Company Revenue Ranking in 2023
3.2 Global Transdermal Patch Revenue by Company (2019-2024)
3.3 Global Transdermal Patch Sales Volume by Company (2019-2024)
3.4 Global Transdermal Patch Average Price by Company (2019-2024)
3.5 Global Transdermal Patch Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Transdermal Patch Company Manufacturing Base & Headquarters
3.7 Global Transdermal Patch Company, Product Type & Application
3.8 Global Transdermal Patch Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Transdermal Patch Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Transdermal Patch Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 TRANSDERMAL PATCH MARKET BY TYPE
4.1 Transdermal Patch Type Introduction
4.1.1 Methyl Salicylate-based Patch
4.1.2 Rivastigmine Transdermal Patch
4.1.3 Fentanyl Transdermal Patch
4.1.4 Lidocaine Patch
4.1.5 Diclofenac Patch
4.1.6 Nicotine Transdermal Patch
4.1.7 Others
4.2 Global Transdermal Patch Sales Volume by Type
4.2.1 Global Transdermal Patch Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Transdermal Patch Sales Volume by Type (2019-2030)
4.2.3 Global Transdermal Patch Sales Volume Share by Type (2019-2030)
4.3 Global Transdermal Patch Sales Value by Type
4.3.1 Global Transdermal Patch Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Transdermal Patch Sales Value by Type (2019-2030)
4.3.3 Global Transdermal Patch Sales Value Share by Type (2019-2030)
5 TRANSDERMAL PATCH MARKET BY APPLICATION
5.1 Transdermal Patch Application Introduction
5.1.1 Rx Channel
5.1.2 OTC Channel
5.2 Global Transdermal Patch Sales Volume by Application
5.2.1 Global Transdermal Patch Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Transdermal Patch Sales Volume by Application (2019-2030)
5.2.3 Global Transdermal Patch Sales Volume Share by Application (2019-2030)
5.3 Global Transdermal Patch Sales Value by Application
5.3.1 Global Transdermal Patch Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Transdermal Patch Sales Value by Application (2019-2030)
5.3.3 Global Transdermal Patch Sales Value Share by Application (2019-2030)
6 TRANSDERMAL PATCH MARKET BY REGION
6.1 Global Transdermal Patch Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Transdermal Patch Sales by Region (2019-2030)
6.2.1 Global Transdermal Patch Sales by Region: 2019-2024
6.2.2 Global Transdermal Patch Sales by Region (2025-2030)
6.3 Global Transdermal Patch Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Transdermal Patch Sales Value by Region (2019-2030)
6.4.1 Global Transdermal Patch Sales Value by Region: 2019-2024
6.4.2 Global Transdermal Patch Sales Value by Region (2025-2030)
6.5 Global Transdermal Patch Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Transdermal Patch Sales Value (2019-2030)
6.6.2 North America Transdermal Patch Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Transdermal Patch Sales Value (2019-2030)
6.7.2 Europe Transdermal Patch Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Transdermal Patch Sales Value (2019-2030)
6.8.2 Asia-Pacific Transdermal Patch Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Transdermal Patch Sales Value (2019-2030)
6.9.2 Latin America Transdermal Patch Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Transdermal Patch Sales Value (2019-2030)
6.10.2 Middle East & Africa Transdermal Patch Sales Value Share by Country, 2023 VS 2030
7 TRANSDERMAL PATCH MARKET BY COUNTRY
7.1 Global Transdermal Patch Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Transdermal Patch Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Transdermal Patch Sales by Country (2019-2030)
7.3.1 Global Transdermal Patch Sales by Country (2019-2024)
7.3.2 Global Transdermal Patch Sales by Country (2025-2030)
7.4 Global Transdermal Patch Sales Value by Country (2019-2030)
7.4.1 Global Transdermal Patch Sales Value by Country (2019-2024)
7.4.2 Global Transdermal Patch Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.5.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.6.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.7.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.8.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.9.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.10.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.11.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.12.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.13.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.14.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.15.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.16.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.17.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.18.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.19.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.20.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.21.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.22.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.23.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Hisamitsu Pharmaceutical
8.1.1 Hisamitsu Pharmaceutical Comapny Information
8.1.2 Hisamitsu Pharmaceutical Business Overview
8.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.1.4 Hisamitsu Pharmaceutical Transdermal Patch Product Portfolio
8.1.5 Hisamitsu Pharmaceutical Recent Developments
8.2 Johnson & Johnson
8.2.1 Johnson & Johnson Comapny Information
8.2.2 Johnson & Johnson Business Overview
8.2.3 Johnson & Johnson Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.2.4 Johnson & Johnson Transdermal Patch Product Portfolio
8.2.5 Johnson & Johnson Recent Developments
8.3 Novartis
8.3.1 Novartis Comapny Information
8.3.2 Novartis Business Overview
8.3.3 Novartis Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.3.4 Novartis Transdermal Patch Product Portfolio
8.3.5 Novartis Recent Developments
8.4 UCB Pharma
8.4.1 UCB Pharma Comapny Information
8.4.2 UCB Pharma Business Overview
8.4.3 UCB Pharma Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.4.4 UCB Pharma Transdermal Patch Product Portfolio
8.4.5 UCB Pharma Recent Developments
8.5 Mylan
8.5.1 Mylan Comapny Information
8.5.2 Mylan Business Overview
8.5.3 Mylan Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.5.4 Mylan Transdermal Patch Product Portfolio
8.5.5 Mylan Recent Developments
8.6 Teva Pharmaceutical
8.6.1 Teva Pharmaceutical Comapny Information
8.6.2 Teva Pharmaceutical Business Overview
8.6.3 Teva Pharmaceutical Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.6.4 Teva Pharmaceutical Transdermal Patch Product Portfolio
8.6.5 Teva Pharmaceutical Recent Developments
8.7 Nitto Denko
8.7.1 Nitto Denko Comapny Information
8.7.2 Nitto Denko Business Overview
8.7.3 Nitto Denko Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.7.4 Nitto Denko Transdermal Patch Product Portfolio
8.7.5 Nitto Denko Recent Developments
8.8 Grьnenthal
8.8.1 Grьnenthal Comapny Information
8.8.2 Grьnenthal Business Overview
8.8.3 Grьnenthal Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.8.4 Grьnenthal Transdermal Patch Product Portfolio
8.8.5 Grьnenthal Recent Developments
8.9 IBSA Group
8.9.1 IBSA Group Comapny Information
8.9.2 IBSA Group Business Overview
8.9.3 IBSA Group Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.9.4 IBSA Group Transdermal Patch Product Portfolio
8.9.5 IBSA Group Recent Developments
8.10 GSK
8.10.1 GSK Comapny Information
8.10.2 GSK Business Overview
8.10.3 GSK Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.10.4 GSK Transdermal Patch Product Portfolio
8.10.5 GSK Recent Developments
8.11 Luye Pharma Group
8.11.1 Luye Pharma Group Comapny Information
8.11.2 Luye Pharma Group Business Overview
8.11.3 Luye Pharma Group Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.11.4 Luye Pharma Group Transdermal Patch Product Portfolio
8.11.5 Luye Pharma Group Recent Developments
8.12 Pfizer
8.12.1 Pfizer Comapny Information
8.12.2 Pfizer Business Overview
8.12.3 Pfizer Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.12.4 Pfizer Transdermal Patch Product Portfolio
8.12.5 Pfizer Recent Developments
8.13 Chattem
8.13.1 Chattem Comapny Information
8.13.2 Chattem Business Overview
8.13.3 Chattem Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.13.4 Chattem Transdermal Patch Product Portfolio
8.13.5 Chattem Recent Developments
8.14 Dr Reddy’s Laboratories
8.14.1 Dr Reddy’s Laboratories Comapny Information
8.14.2 Dr Reddy’s Laboratories Business Overview
8.14.3 Dr Reddy’s Laboratories Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.14.4 Dr Reddy’s Laboratories Transdermal Patch Product Portfolio
8.14.5 Dr Reddy’s Laboratories Recent Developments
8.15 Bayer
8.15.1 Bayer Comapny Information
8.15.2 Bayer Business Overview
8.15.3 Bayer Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.15.4 Bayer Transdermal Patch Product Portfolio
8.15.5 Bayer Recent Developments
8.16 Mundipharma
8.16.1 Mundipharma Comapny Information
8.16.2 Mundipharma Business Overview
8.16.3 Mundipharma Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.16.4 Mundipharma Transdermal Patch Product Portfolio
8.16.5 Mundipharma Recent Developments
8.17 Endo International
8.17.1 Endo International Comapny Information
8.17.2 Endo International Business Overview
8.17.3 Endo International Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.17.4 Endo International Transdermal Patch Product Portfolio
8.17.5 Endo International Recent Developments
8.18 Beijing Tide Pharmaceutical
8.18.1 Beijing Tide Pharmaceutical Comapny Information
8.18.2 Beijing Tide Pharmaceutical Business Overview
8.18.3 Beijing Tide Pharmaceutical Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.18.4 Beijing Tide Pharmaceutical Transdermal Patch Product Portfolio
8.18.5 Beijing Tide Pharmaceutical Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Transdermal Patch Value Chain Analysis
9.1.1 Transdermal Patch Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Transdermal Patch Sales Mode & Process
9.2 Transdermal Patch Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Transdermal Patch Distributors
9.2.3 Transdermal Patch Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Transdermal Patch Sales Value (2019-2030)
1.2.2 Global Transdermal Patch Sales Volume (2019-2030)
1.2.3 Global Transdermal Patch Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 TRANSDERMAL PATCH MARKET DYNAMICS
2.1 Transdermal Patch Industry Trends
2.2 Transdermal Patch Industry Drivers
2.3 Transdermal Patch Industry Opportunities and Challenges
2.4 Transdermal Patch Industry Restraints
3 TRANSDERMAL PATCH MARKET BY COMPANY
3.1 Global Transdermal Patch Company Revenue Ranking in 2023
3.2 Global Transdermal Patch Revenue by Company (2019-2024)
3.3 Global Transdermal Patch Sales Volume by Company (2019-2024)
3.4 Global Transdermal Patch Average Price by Company (2019-2024)
3.5 Global Transdermal Patch Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Transdermal Patch Company Manufacturing Base & Headquarters
3.7 Global Transdermal Patch Company, Product Type & Application
3.8 Global Transdermal Patch Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Transdermal Patch Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Transdermal Patch Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 TRANSDERMAL PATCH MARKET BY TYPE
4.1 Transdermal Patch Type Introduction
4.1.1 Methyl Salicylate-based Patch
4.1.2 Rivastigmine Transdermal Patch
4.1.3 Fentanyl Transdermal Patch
4.1.4 Lidocaine Patch
4.1.5 Diclofenac Patch
4.1.6 Nicotine Transdermal Patch
4.1.7 Others
4.2 Global Transdermal Patch Sales Volume by Type
4.2.1 Global Transdermal Patch Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Transdermal Patch Sales Volume by Type (2019-2030)
4.2.3 Global Transdermal Patch Sales Volume Share by Type (2019-2030)
4.3 Global Transdermal Patch Sales Value by Type
4.3.1 Global Transdermal Patch Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Transdermal Patch Sales Value by Type (2019-2030)
4.3.3 Global Transdermal Patch Sales Value Share by Type (2019-2030)
5 TRANSDERMAL PATCH MARKET BY APPLICATION
5.1 Transdermal Patch Application Introduction
5.1.1 Rx Channel
5.1.2 OTC Channel
5.2 Global Transdermal Patch Sales Volume by Application
5.2.1 Global Transdermal Patch Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Transdermal Patch Sales Volume by Application (2019-2030)
5.2.3 Global Transdermal Patch Sales Volume Share by Application (2019-2030)
5.3 Global Transdermal Patch Sales Value by Application
5.3.1 Global Transdermal Patch Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Transdermal Patch Sales Value by Application (2019-2030)
5.3.3 Global Transdermal Patch Sales Value Share by Application (2019-2030)
6 TRANSDERMAL PATCH MARKET BY REGION
6.1 Global Transdermal Patch Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Transdermal Patch Sales by Region (2019-2030)
6.2.1 Global Transdermal Patch Sales by Region: 2019-2024
6.2.2 Global Transdermal Patch Sales by Region (2025-2030)
6.3 Global Transdermal Patch Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Transdermal Patch Sales Value by Region (2019-2030)
6.4.1 Global Transdermal Patch Sales Value by Region: 2019-2024
6.4.2 Global Transdermal Patch Sales Value by Region (2025-2030)
6.5 Global Transdermal Patch Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Transdermal Patch Sales Value (2019-2030)
6.6.2 North America Transdermal Patch Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Transdermal Patch Sales Value (2019-2030)
6.7.2 Europe Transdermal Patch Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Transdermal Patch Sales Value (2019-2030)
6.8.2 Asia-Pacific Transdermal Patch Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Transdermal Patch Sales Value (2019-2030)
6.9.2 Latin America Transdermal Patch Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Transdermal Patch Sales Value (2019-2030)
6.10.2 Middle East & Africa Transdermal Patch Sales Value Share by Country, 2023 VS 2030
7 TRANSDERMAL PATCH MARKET BY COUNTRY
7.1 Global Transdermal Patch Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Transdermal Patch Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Transdermal Patch Sales by Country (2019-2030)
7.3.1 Global Transdermal Patch Sales by Country (2019-2024)
7.3.2 Global Transdermal Patch Sales by Country (2025-2030)
7.4 Global Transdermal Patch Sales Value by Country (2019-2030)
7.4.1 Global Transdermal Patch Sales Value by Country (2019-2024)
7.4.2 Global Transdermal Patch Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.5.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.6.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.7.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.8.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.9.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.10.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.11.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.12.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.13.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.14.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.15.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.16.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.17.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.18.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.19.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.20.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.21.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.22.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Transdermal Patch Sales Value Growth Rate (2019-2030)
7.23.2 Global Transdermal Patch Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Transdermal Patch Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Hisamitsu Pharmaceutical
8.1.1 Hisamitsu Pharmaceutical Comapny Information
8.1.2 Hisamitsu Pharmaceutical Business Overview
8.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.1.4 Hisamitsu Pharmaceutical Transdermal Patch Product Portfolio
8.1.5 Hisamitsu Pharmaceutical Recent Developments
8.2 Johnson & Johnson
8.2.1 Johnson & Johnson Comapny Information
8.2.2 Johnson & Johnson Business Overview
8.2.3 Johnson & Johnson Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.2.4 Johnson & Johnson Transdermal Patch Product Portfolio
8.2.5 Johnson & Johnson Recent Developments
8.3 Novartis
8.3.1 Novartis Comapny Information
8.3.2 Novartis Business Overview
8.3.3 Novartis Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.3.4 Novartis Transdermal Patch Product Portfolio
8.3.5 Novartis Recent Developments
8.4 UCB Pharma
8.4.1 UCB Pharma Comapny Information
8.4.2 UCB Pharma Business Overview
8.4.3 UCB Pharma Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.4.4 UCB Pharma Transdermal Patch Product Portfolio
8.4.5 UCB Pharma Recent Developments
8.5 Mylan
8.5.1 Mylan Comapny Information
8.5.2 Mylan Business Overview
8.5.3 Mylan Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.5.4 Mylan Transdermal Patch Product Portfolio
8.5.5 Mylan Recent Developments
8.6 Teva Pharmaceutical
8.6.1 Teva Pharmaceutical Comapny Information
8.6.2 Teva Pharmaceutical Business Overview
8.6.3 Teva Pharmaceutical Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.6.4 Teva Pharmaceutical Transdermal Patch Product Portfolio
8.6.5 Teva Pharmaceutical Recent Developments
8.7 Nitto Denko
8.7.1 Nitto Denko Comapny Information
8.7.2 Nitto Denko Business Overview
8.7.3 Nitto Denko Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.7.4 Nitto Denko Transdermal Patch Product Portfolio
8.7.5 Nitto Denko Recent Developments
8.8 Grьnenthal
8.8.1 Grьnenthal Comapny Information
8.8.2 Grьnenthal Business Overview
8.8.3 Grьnenthal Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.8.4 Grьnenthal Transdermal Patch Product Portfolio
8.8.5 Grьnenthal Recent Developments
8.9 IBSA Group
8.9.1 IBSA Group Comapny Information
8.9.2 IBSA Group Business Overview
8.9.3 IBSA Group Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.9.4 IBSA Group Transdermal Patch Product Portfolio
8.9.5 IBSA Group Recent Developments
8.10 GSK
8.10.1 GSK Comapny Information
8.10.2 GSK Business Overview
8.10.3 GSK Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.10.4 GSK Transdermal Patch Product Portfolio
8.10.5 GSK Recent Developments
8.11 Luye Pharma Group
8.11.1 Luye Pharma Group Comapny Information
8.11.2 Luye Pharma Group Business Overview
8.11.3 Luye Pharma Group Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.11.4 Luye Pharma Group Transdermal Patch Product Portfolio
8.11.5 Luye Pharma Group Recent Developments
8.12 Pfizer
8.12.1 Pfizer Comapny Information
8.12.2 Pfizer Business Overview
8.12.3 Pfizer Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.12.4 Pfizer Transdermal Patch Product Portfolio
8.12.5 Pfizer Recent Developments
8.13 Chattem
8.13.1 Chattem Comapny Information
8.13.2 Chattem Business Overview
8.13.3 Chattem Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.13.4 Chattem Transdermal Patch Product Portfolio
8.13.5 Chattem Recent Developments
8.14 Dr Reddy’s Laboratories
8.14.1 Dr Reddy’s Laboratories Comapny Information
8.14.2 Dr Reddy’s Laboratories Business Overview
8.14.3 Dr Reddy’s Laboratories Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.14.4 Dr Reddy’s Laboratories Transdermal Patch Product Portfolio
8.14.5 Dr Reddy’s Laboratories Recent Developments
8.15 Bayer
8.15.1 Bayer Comapny Information
8.15.2 Bayer Business Overview
8.15.3 Bayer Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.15.4 Bayer Transdermal Patch Product Portfolio
8.15.5 Bayer Recent Developments
8.16 Mundipharma
8.16.1 Mundipharma Comapny Information
8.16.2 Mundipharma Business Overview
8.16.3 Mundipharma Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.16.4 Mundipharma Transdermal Patch Product Portfolio
8.16.5 Mundipharma Recent Developments
8.17 Endo International
8.17.1 Endo International Comapny Information
8.17.2 Endo International Business Overview
8.17.3 Endo International Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.17.4 Endo International Transdermal Patch Product Portfolio
8.17.5 Endo International Recent Developments
8.18 Beijing Tide Pharmaceutical
8.18.1 Beijing Tide Pharmaceutical Comapny Information
8.18.2 Beijing Tide Pharmaceutical Business Overview
8.18.3 Beijing Tide Pharmaceutical Transdermal Patch Sales, Value and Gross Margin (2019-2024)
8.18.4 Beijing Tide Pharmaceutical Transdermal Patch Product Portfolio
8.18.5 Beijing Tide Pharmaceutical Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Transdermal Patch Value Chain Analysis
9.1.1 Transdermal Patch Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Transdermal Patch Sales Mode & Process
9.2 Transdermal Patch Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Transdermal Patch Distributors
9.2.3 Transdermal Patch Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
